PROVIDED IS THE USE OF A SALVIA MILTIORRHIZA COMPOSITION IN PREPARING DRUGS FOR SECONDARY PREVENTION OF CORONARY HEART DISEASE, AND PARTICULARLY THE USE OF THE SALVIA MLLTIORRHIZA COMPOSITION IN PREPARING DRUGS FOR SECONDARY PREVENTION OF STABLE ANGINA TYPE CORONARY HEART DISEASE AND THE REDUCTION OF SERIOUS VASCULAR EVENTS.